IDEXX LABORATORIES INC /DE — Director's Dealing 2021

Feb 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-02-14

Reporting Person: Turner Kathy V (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-14	Common Stock	M	221	—	Acquired	10376	Direct
2021-02-14	Common Stock	M	212	—	Acquired	10588	Direct
2021-02-14	Common Stock	M	210	—	Acquired	10798	Direct
2021-02-14	Common Stock	M	181	—	Acquired	10979	Direct
2021-02-14	Common Stock	M	163	—	Acquired	11142	Direct
2021-02-14	Common Stock	F	388	$544.08	Disposed	10754	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-14	Non-Qualified Stock Option (right-to-buy)	$544.08	A	3131	Acquired	2021-02-13	Common Stock (3131)	Direct
2021-02-14	Incentive Stock Option (right-to-buy)	$544.08	A	183	Acquired	2031-02-13	Common Stock (183)	Direct
2021-02-14	Restricted Stock Unit	$	A	345	Acquired		Common Stock (345)	Direct
2021-02-14	Restricted Stock Unit	$	M	221	Disposed		Common Stock (221)	Direct
2021-02-14	Restricted Stock Unit	$	M	212	Disposed		Common Stock (212)	Direct
2021-02-14	Restricted Stock Unit	$	M	210	Disposed		Common Stock (210)	Direct
2021-02-14	Restricted Stock Unit	$	M	181	Disposed		Common Stock (181)	Direct
2021-02-14	Restricted Stock Unit	$	M	163	Disposed		Common Stock (163)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	100	Indirect

Footnotes

F1: Includes a total of 43 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2020, September 30, 2020 and December 31, 2020.

F2: The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein.

F3: Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021.

F4: Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2022.

F5: Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant.

F6: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.

F7: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2017.

F8: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.

F9: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019.

F10: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

F11: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.

F12: Not applicable.